GoldBamboo.com - Knowledge is strong medicine
  

Continuous Delivery of Levodopa in Patients With Advanced Idiopathic Parkinsons Disease - Cost-Benefit - Article


  Not Signed In - Sign In / Register


Get Your Free Credit Report Right Now!

Zip Code:



General Topics A-Z

Wolff-Parkinson-White Syndrome

WPW 



Clinical Trial: Continuous Delivery of Levodopa in Patients With Advanced Idiopathic Parkinsons Disease - Cost-Benefit

This study is not yet open for patient recruitment.
Verified by Akershus University Hospital January 2006

Sponsors and Collaborators: Akershus University Hospital
Solvay Pharmaceuticals
Information provided by: Akershus University Hospital
ClinicalTrials.gov Identifier: NCT00272688

Purpose

An open, observational health economic study to estimate marginal cost and health consequences of replacing conventional Parkinsons disease therapy with intraduodenal levodopa administered continuously
Condition Intervention Phase
Parkinson Disease
  Drug: Levodopa (drug), intraduodenal administration
 Phase IV

MedlinePlus related topics:  Parkinson''''s Disease
Genetics Home Reference related topics:  Parkinson disease

Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Single Group Assignment

Official Title: Continuous Delivery of Levodopa/Carbidopa (Duodopa) in Patients With Advanced Idiopathic Parkinsons Disease - a Health Economic Evaluation

Further study details as provided by Akershus University Hospital:

Study start: January 2006

Eligibility

Genders Eligible for Study:  Both
Criteria

Inclusion Criteria:

Exclusion Criteria:

  • Severe dementia, confusion, psychosis or depression
  • Patients with contraindications aginst levodopa treatment

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00272688

Christofer Lundqvist, PhD, M.D.      +47 67929466    anderchr@medisin.uio.no
Antonie Beiske, M.D.      +47 67928800    antonie.beiske@ahus.no

Norway
      Akershus University Hospital, Nordbyhagen,  1474,  Norway
Antonie Beiske, M.D.  +47 67928800    antonie.beiske@ahus.no 

      Dept Neurology, Ulleval University Hospital, Oslo,  0450,  Norway
Christofer Lundqvist, PhD, M.D.  +47 22118672    luch@ulleval.no 

Study chairs or principal investigators

Christofer Lundqvist, PhD, M.D.,  Principal Investigator,  HØKH - Helse Ost Health Services Research Centre, Akershus University Hospital, Norway   
Antonie Beiske, PhD, M.D.,  Principal Investigator,  Dept Neurology, Akershus University Hospital, Norway   

More Information

Study ID Numbers:  Duo-HRQoL-2
Last Updated:  January 6, 2006
Record first received:  January 6, 2006
ClinicalTrials.gov Identifier:  NCT00272688
Health Authority: Norway: Norwegian Medicines Agency
ClinicalTrials.gov processed this record on 2006-01-10


Source: ClinicalTrials.gov
Cache Date: January 11, 2006

Resources



[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]

Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $30 a year, a savings of 70% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Wolff-Parkinson-White Syndrome.

November 29, 2009


Page Updated: October 15, 2009
============== Advertisement ==============
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Health Forums

Copyright © 2004-2009 - Anaconda Partners LLC - All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.